Skip to main content
Premium Trial:

Request an Annual Quote

Decode Nets $18.4M on Sale, Lease-Back of Chicago Facility

NEW YORK (GenomeWeb News) — Decode Genetics has netted $18.4 million after selling and leasing back its Chicago-area medicinal chemistry facility, the company said today.
 
The company sold the Woodridge, Ill., facility for $25 million and leased the space back for a 17-year term, Decode said.
 
Decode said it plans to use the cash it made on the deal to fund its drug- and diagnostic-development programs.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.